← Open Payments lookup

XINNA YI: Open Payments

NPI 1528740719 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,572 in 68 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $881 · 2025 $1,572

Food & beverage: $1,572
CompanyPaymentsAmount
Gilead Sciences, Inc.4$366
PFIZER INC.18$287
ABBVIE INC.15$256
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$226
Madrigal Pharmaceuticals7$153
Ipsen Biopharmaceuticals, Inc3$89
QOL Medical, LLC3$43
Novo Nordisk Inc2$35
Regeneron Healthcare Solutions, Inc.1$33
Lilly USA, LLC1$25

Products named: XIFAXAN, Vemlidy, XELJANZ, REZDIFFRA, LINZESS, Livdelzi, VELSIPITY, IQIRVO.

Industry payments across DC — which companies pay providers there.